Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
Public ClinicalTrials.gov record NCT01471574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this open label study is to evaluate the safety and efficacy of daclatasvir plus pegylated interferon-alfa 2a and ribavirin in untreated hepatitis C virus in patients coinfected with HIV
Study identification
- NCT ID
- NCT01471574
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 549 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- Jun 2014 (Actual)
- Completion
- Sep 2014 (Actual)
- Last update posted
- Jan 29, 2016
2011 – 2014
United States locations
- U.S. sites
- 23
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University Of Alabama At Birmingham | Birmingham | Alabama | 35294 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Southern California Permanente Medical Group | Los Angeles | California | 90027 | — |
| Desert Medical Group Inc. | Palm Springs | California | 92262 | — |
| Ucsd Antiviral Research Center | San Diego | California | 92103 | — |
| San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Kaiser Permanente Medical Center | San Francisco | California | 94118 | — |
| Va Connecticut Healthcare System | West Haven | Connecticut | 06516 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| University Of Miami School Of Medicine | Miami | Florida | 33136 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Johns Hopkins University | Lutherville | Maryland | 21093 | — |
| Saint Michael'S Medical Center | Newark | New Jersey | 07102 | — |
| Upper Delaware Valley Infectious Diseases, Pc | Monticello | New York | 12701 | — |
| Icahn School Of Medicine At Mount Sinai | New York | New York | 10029 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| James J Peters Vamc | The Bronx | New York | 10468 | — |
| University Of North Carolina At Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Morehead Medical Plaza | Charlotte | North Carolina | 28204 | — |
| Amelia Court Hiv Research Clinic | Dallas | Texas | 75235 | — |
| Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Texas Liver Institute | San Antonio | Texas | 78215 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01471574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2016 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01471574 live on ClinicalTrials.gov.